🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
As a new dual receptor (integrin αvβ3 and FAP) targeting PET radiotracer, 6...
Status
Completed
Location
The First Affiliated Hospital of Xiamen University
Start Date
2022-07-01
Trial ID
NCT05543317
Treatments Being Tested
68Ga-fibroblast activating protein inhibitors(FAPI) has been developed as a...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2021-11-18
Trial ID
NCT05121779
Intestinal stricture is a complication of Crohn's disease (CD), which is th...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09
Trial ID
NCT04502303
Treatments Being Tested
This study aims to explore the value of 68Ga-FAPI PET/CT in the diagnosis o...
Status
Unknown
Location
Department of Gastric Surgery
Start Date
2021-03
Trial ID
NCT04778345
Treatments Being Tested
To evaluate the potential usefulness of 18F-AlF-FAPI positron emission tomo...
Status
Completed
Location
The First affiliated hospital of xiamen university
Start Date
2022-06-01
Trial ID
NCT05430841
Treatments Being Tested
To evaluate the normal physiological distribution of positron nuclide label...
Status
Unknown
Location
Peking University Cancer Hospital
Start Date
2019-10-16
Trial ID
NCT04750772
Treatments Being Tested
This is the first-in-human study of 68Ga/64Cu-FAPI-XT117, which is an prosp...
Status
Completed
Location
the First Medical Center, Chinese PLA General Hospital
Start Date
2022-12-07
Trial ID
NCT05814835
Treatments Being Tested
1. Goal of the Study: The goal of this prospective observational study ...
Status
Enrolling By Invitation
Location
Beijing Anzhen Hospital
Start Date
2025-02-13
Trial ID
NCT07103863
To evaluate the potential usefulness of 18F-AlF-FAPI positron emission tomo...
Status
Recruiting
Location
Dept. of Nuclear Medicine, Peking University Third Hospital
Start Date
2024-07-16
Trial ID
NCT06791226
Treatments Being Tested
The goal of this observational study is to examine clinical utility of 18F-...
Status
Unknown
Location
Sichuan Provincial People's Hospital
Start Date
2023-08-16
Trial ID
NCT06143540